Oscar Health expects explosive growth for 2026, but it comes with a risknews2026-02-11T14:32:46+00:00February 11th, 2026|Endpoints News|
Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point? news2026-02-11T14:21:30+00:00February 11th, 2026|Endpoints News|
Sanofi invests in China startup GluBio in developing molecular glue for sickle cellnews2026-02-11T12:00:02+00:00February 11th, 2026|Endpoints News|
Upstream Bio’s stock slides on Phase 2 severe asthma data for verekitugnews2026-02-11T11:57:14+00:00February 11th, 2026|Endpoints News|
Moderna accuses FDA of shifting standard as agency refuses flu shot reviewnews2026-02-10T23:00:09+00:00February 10th, 2026|Endpoints News|
Isomorphic claims major advance with new AI drug design enginenews2026-02-10T20:33:26+00:00February 10th, 2026|Endpoints News|
ILiAD raises $115M round to advance whooping cough vaccinenews2026-02-10T20:26:55+00:00February 10th, 2026|Endpoints News|
AbbVie, AstraZeneca lose appeal in Louisiana 340B contract pharmacy fightnews2026-02-10T20:06:24+00:00February 10th, 2026|Endpoints News|
NIH stops low-dose Xarelto arm of large stroke study due to safety concernsnews2026-02-10T19:55:14+00:00February 10th, 2026|Endpoints News|
Is AstraZeneca on track to meet its $80B revenue target?news2026-02-10T16:34:33+00:00February 10th, 2026|Endpoints News|
